Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Ying Yan

Matched on ORCID iD 0000-0002-3546-3991; OpenAlex author ID A5030191700; NIH RePORTER profile ID 8878285. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
31
Papers, trials and grants by year

2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 grant · 2025: none · 2026: 1 paper

Papers 13

  1. Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells to Gamma Rays. Co-author DOI 10.3390/cancers18121908↗
  2. The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells. Co-author DOI 10.1016/j.neo.2022.01.002↗
  3. The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0273518↗
  4. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Co-author DOI 10.18632/oncotarget.27450↗
  5. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Last author DOI 10.1038/s41389-019-0172-9↗
  6. Biological determinants of radioresistance and their remediation in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2017.02.003↗
  7. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.19410↗
  8. PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signal… Last author DOI 10.1158/0008-5472.can-15-2119↗
  9. Sensitization of Radiation or Gemcitabine-Based Chemoradiation Therapeutic Effect by Nimotuzumab in Pancreatic Cancer Cells. Co-author DOI 10.1177/1533034615585209↗
  10. Rac1 GTPase in pancreatic cancer. Co-author DOI 10.18632/aging.100804↗
  11. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
  12. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. First author DOI 10.1371/journal.pone.0085155↗
  13. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Co-author DOI 10.18632/oncotarget.2500↗

Grants 1

  1. PR55-alpha controlled PP2A in the regulation of the Hippo/YAP pathway R01GM143329↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michel M. Ouellette · 10 shared papers, 2014–2026 · strength 1.21
  2. Surinder K. Batra · 9 shared papers, 2014–2026 · strength 1.08
  3. Neha Chaudhary · 2 shared papers, 2022–2026 · strength 0.56
  4. Parthasarathy Seshacharyulu · 5 shared papers, 2015–2022 · strength 0.45
  5. Katrina M. Burchett · 4 shared papers, 2014–2020 · strength 0.32
  6. Ashley L. Hein · 4 shared papers, 2014–2020 · strength 0.32
  7. Chi H. Lin · 3 shared papers, 2014–2020 · strength 0.22
  8. Chitra Palanivel · 1 shared paper, 2022 · strength 0.17
  9. Jesse L. Cox · 1 shared paper, 2022 · strength 0.17
  10. Kenneth H. Cowan · 2 shared papers, 2014–2020 · strength 0.16
  11. Jennifer D. Black · 1 shared paper, 2022 · strength 0.15
  12. Shelby M. Knoche · 1 shared paper, 2022 · strength 0.15
  13. Brittany J. Poelaert · 1 shared paper, 2022 · strength 0.15
  14. Alaina C. Larson · 1 shared paper, 2022 · strength 0.15
  15. Bailee H. Sliker · 1 shared paper, 2022 · strength 0.15
  16. Madeline T. Olson · 1 shared paper, 2022 · strength 0.15
  17. Joyce C. Solheim · 1 shared paper, 2022 · strength 0.15
  18. Maneesh Jain · 2 shared papers, 2015–2017 · strength 0.11
  19. Moorthy Palanimuthu Ponnusamy · 2 shared papers, 2015–2016 · strength 0.10
  20. Satyanarayana Rachagani · 2 shared papers, 2015–2016 · strength 0.10
  21. Joshua J. Souchek · 1 shared paper, 2017 · strength 0.07
  22. Sukhwinder Kaur · 1 shared paper, 2017 · strength 0.07
  23. Michael J. Baine · 1 shared paper, 2017 · strength 0.07
  24. Chunzi Gao · 1 shared paper, 2016 · strength 0.07
  25. Bo Han · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.